Insulet (NSDQ:PODD) is suing Roche Diabetes Care in the U.K., claiming that Roche prematurely began selling tubeless insulin pumps covered by an Insulet patent three years before that patent expires.
The trial for the lawsuit, filed in August 2020, began this week in the U.K. High Court.
Get the full story on our sister site, Drug Delivery Business News.
BioCorp and Roche Diabetes Care France announced the launch of the Mallya smart insulin pen device in France.
Developed by BioCorp, Mallya is an intelligent sensor for insulin injection pens that has CE mark approval in Europe. The platform is compatible with any disposable insulin pen. It enables reliable monitoring for doses selected for injection and it offers patients with diabetes better compliance with their treatment, according to the companies.
Get the full story at our sister site, Drug Delivery Business News.